HUIZE HOLDING LTD-ADR (HUIZ)

US44473E1055 - ADR

2.73  -0.01 (-0.36%)

Fundamental Rating

4

HUIZ gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 141 industry peers in the Insurance industry. While HUIZ has a great health rating, its profitability is only average at the moment. While showing a medium growth rate, HUIZ is valued expensive at the moment.



4

1. Profitability

1.1 Basic Checks

In the past year HUIZ was profitable.
In the past 5 years HUIZ reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: HUIZ reported negative operating cash flow in multiple years.

1.2 Ratios

HUIZ has a Return On Assets of 7.41%. This is amongst the best in the industry. HUIZ outperforms 88.57% of its industry peers.
HUIZ has a Return On Equity of 17.32%. This is in the better half of the industry: HUIZ outperforms 72.86% of its industry peers.
With an excellent Return On Invested Capital value of 7.30%, HUIZ belongs to the best of the industry, outperforming 89.29% of the companies in the same industry.
Industry RankSector Rank
ROA 7.41%
ROE 17.32%
ROIC 7.3%
ROA(3y)-0.42%
ROA(5y)-1.57%
ROE(3y)-7.25%
ROE(5y)-8.74%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

HUIZ's Profit Margin of 5.87% is in line compared to the rest of the industry. HUIZ outperforms 45.71% of its industry peers.
Looking at the Operating Margin, with a value of 4.27%, HUIZ is doing worse than 71.43% of the companies in the same industry.
In the last couple of years the Operating Margin of HUIZ has declined.
HUIZ's Gross Margin of 37.35% is amongst the best of the industry. HUIZ outperforms 92.14% of its industry peers.
In the last couple of years the Gross Margin of HUIZ has remained more or less at the same level.
Industry RankSector Rank
OM 4.27%
PM (TTM) 5.87%
GM 37.35%
OM growth 3YN/A
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.11%
GM growth 5Y-0.05%

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HUIZ is creating some value.
HUIZ has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HUIZ has less shares outstanding
Compared to 1 year ago, HUIZ has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.13 indicates that HUIZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of HUIZ (2.13) is better than 92.14% of its industry peers.
There is no outstanding debt for HUIZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.13
ROIC/WACC1.04
WACC7.02%

2.3 Liquidity

HUIZ has a Current Ratio of 1.53. This is a normal value and indicates that HUIZ is financially healthy and should not expect problems in meeting its short term obligations.
HUIZ has a Current ratio of 1.53. This is amongst the best in the industry. HUIZ outperforms 90.00% of its industry peers.
A Quick Ratio of 1.53 indicates that HUIZ should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.53, HUIZ belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.53

4

3. Growth

3.1 Past

HUIZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 327.13%, which is quite impressive.
Looking at the last year, HUIZ shows a small growth in Revenue. The Revenue has grown by 3.25% in the last year.
HUIZ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.63% yearly.
EPS 1Y (TTM)327.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.4%
Revenue 1Y (TTM)3.25%
Revenue growth 3Y-0.68%
Revenue growth 5Y18.63%
Sales Q2Q%-8.67%

3.2 Future

HUIZ is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -26.11% yearly.
HUIZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.40% yearly.
EPS Next Y-75.61%
EPS Next 2Y-46.6%
EPS Next 3Y-26.11%
EPS Next 5YN/A
Revenue Next Year-13.16%
Revenue Next 2Y-2.06%
Revenue Next 3Y3.4%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.37, HUIZ is valued correctly.
HUIZ's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.77, HUIZ is valued rather cheaply.
A Price/Forward Earnings ratio of 74.99 indicates a quite expensive valuation of HUIZ.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HUIZ indicates a rather expensive valuation: HUIZ more expensive than 80.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.38, HUIZ is valued quite expensively.
Industry RankSector Rank
PE 14.37
Fwd PE 74.99

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

HUIZ's earnings are expected to decrease with -26.11% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-46.6%
EPS Next 3Y-26.11%

0

5. Dividend

5.1 Amount

No dividends for HUIZ!.
Industry RankSector Rank
Dividend Yield N/A

HUIZE HOLDING LTD-ADR

NASDAQ:HUIZ (12/18/2024, 4:30:01 PM)

2.73

-0.01 (-0.36%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap135.40M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 14.37
Fwd PE 74.99
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.41%
ROE 17.32%
ROCE
ROIC
ROICexc
ROICexgc
OM 4.27%
PM (TTM) 5.87%
GM 37.35%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.53
Quick Ratio 1.53
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)327.13%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-75.61%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.25%
Revenue growth 3Y-0.68%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y